Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Mundipharma“
Suchtreffer
Begriffe & Kennungen
Cegfila (previously Pegfilgrastim Mundipharma)
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.1 Therapeutic indications · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.3 Contraindications · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ Cegfila should b
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not been specifically invest
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Specific interaction or metabolism studies have not been performed, however, clinical trials have not indicate
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · The potential for interaction with lithium, which also promotes the release of neutrophils, has not been speci
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · The safety and efficacy of Cegfila have not been evaluated in patients receiving chemotherapy associated with
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 Undesirable effects · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · 6 MedDRA Adverse reactions system organ Very Common Uncommon Rare Very rare class common (≥ 1/10) (≥ 1/100 (≥
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · 7 MedDRA Adverse reactions system organ Very Common Uncommon Rare Very rare class common (≥ 1/10) (≥ 1/100 (≥
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · An increased risk of MDS/AML following treatment with pegfilgrastim in conjunction with chemotherapy and/or ra
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Capillary leak syndrome, which can be life-threatening if treatment is delayed, has been reported as uncommon
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Cases of capillary leak syndrome have been reported in the post marketing setting with granulocyte colony-stim
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Common cases of leukocytosis (White Blood Count [WBC] > 100 × 109/L) have been reported (see section 4.4).
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Common cases of thrombocytopenia have been reported.
Eintrag öffnen